T1	PROC 1 20	Estudio comparativo
#1	AnnotatorNotes T1	C1579762; comparative study research; Research Activity
T2	CHEM 68 78	meperidina
#2	AnnotatorNotes T2	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T3	PROC 103 130	infiltración periprostática
T4	CHEM 135 144	lidocaína
#3	AnnotatorNotes T4	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T5	PROC 148 182	biopsias transrectales de próstata
#4	AnnotatorNotes T5	C0401641; Transrectal biopsy of prostate; Diagnostic Procedure
T6	ANAT 174 182	próstata
#5	AnnotatorNotes T6	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T7	PROC 194 213	Evaluar la eficacia
#6	AnnotatorNotes T7	C1707887; Efficacy Study; Research Activity
T8	PROC 220 241	analgesia intravenosa
T9	CHEM 246 256	meperidina
#7	AnnotatorNotes T9	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T10	PROC 742 765	Escala Analógico Visual
#8	AnnotatorNotes T10	C0042815; Visual Analog Pain Scale; Diagnostic Procedure
T11	ANAT 286 306	plexo periprostático
T12	CHEM 311 320	lidocaína
#9	AnnotatorNotes T12	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T13	PROC 339 369	anestesia local periprostática
T14	PROC 392 424	Estudio prospectivo aleatorizado
#10	AnnotatorNotes T14	C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T15	PROC 473 492	biopsia de próstata
#11	AnnotatorNotes T15	C0194804; Biopsy of prostate; Diagnostic Procedure
T16	ANAT 684 706	ángulo prostatoseminal
T17	CHEM 662 671	lidocaína
#12	AnnotatorNotes T17	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T18	DISO 918 932	complicaciones
#13	AnnotatorNotes T18	C0009566; Complication; Pathologic Function
T19	PROC 952 959	biopsia
#14	AnnotatorNotes T19	C0005558; Biopsy; Diagnostic Procedure
T20	PROC 851 864	procedimiento
#15	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T21	PROC 1179 1197	volumen prostático
#16	AnnotatorNotes T21	C1112586; Prostate volume study; Diagnostic Procedure
T22	ANAT 1187 1197	prostático
#17	AnnotatorNotes T22	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T23	PROC 1296 1303	biopsia
#18	AnnotatorNotes T23	C0005558; Biopsy; Diagnostic Procedure
T24	PROC 1627 1643	toma de cilindro
T25	PROC 1788 1813	test de impacto emocional
T26	DISO 1979 1993	complicaciones
#19	AnnotatorNotes T26	C0009566; Complication; Pathologic Function
T27	CHEM 2034 2044	meperidina
#20	AnnotatorNotes T27	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T28	CHEM 2065 2074	lidocaína
#21	AnnotatorNotes T28	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T29	PROC 2129 2161	bloqueo del plexo periprostático
T30	ANAT 2141 2161	plexo periprostático
T31	CHEM 2166 2175	lidocaína
#22	AnnotatorNotes T31	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T32	CHEM 2221 2231	meperidina
#23	AnnotatorNotes T32	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T33	DISO 2305 2319	complicaciones
#24	AnnotatorNotes T33	C0009566; Complication; Pathologic Function
T34	PROC 767 770	VAS
#25	AnnotatorNotes T34	C0042815; Visual Analog Pain Scale; Diagnostic Procedure
T35	PROC 269 306	infiltración del plexo periprostático
T36	ANAT 484 492	próstata
#26	AnnotatorNotes T36	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T37	CHEM 594 604	meperidina
#27	AnnotatorNotes T37	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T38	DISO 711 716	dolor
#28	AnnotatorNotes T38	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T39	PROC 777 789	cuestionario
#29	AnnotatorNotes T39	C2960239; Assessment using health assessment questionnaire; Health Care Activity | C1882515; Questionnaire Administration; Health Care Activity
T40	PROC 826 832	prueba
#30	AnnotatorNotes T40	C0430022; diagnostic procedure; Diagnostic Procedure (?)
T41	PROC 884 907	cuestionario telefónico
T42	PROC 1174 1177	PSA
#31	AnnotatorNotes T42	C0201544; Prostate specific antigen measurement; Laboratory Procedure
T43	ANAT 1209 1218	cilindros
#32	AnnotatorNotes T43	C3274653; Core Specimen; Body Substance
T44	PROC 1421 1424	VAS
#33	AnnotatorNotes T44	C0042815; Visual Analog Pain Scale; Diagnostic Procedure
T45	ANAT 1372 1381	cilindros
#34	AnnotatorNotes T45	C3274653; Core Specimen; Body Substance
T46	DISO 1537 1542	dolor
#35	AnnotatorNotes T46	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T47	ANAT 1635 1643	cilindro
#36	AnnotatorNotes T47	C3274653; Core Specimen; Body Substance
T48	DISO 1856 1861	dolor
#37	AnnotatorNotes T48	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T49	PROC 1879 1885	prueba
#38	AnnotatorNotes T49	C0430022; diagnostic procedure; Diagnostic Procedure (?)
T50	ANAT 1909 1918	cilindros
#39	AnnotatorNotes T50	C3274653; Core Specimen; Body Substance
T51	PROC 2390 2411	toma de los cilindros
T52	DISO 2370 2375	dolor
#40	AnnotatorNotes T52	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T53	ANAT 2402 2411	cilindros
#41	AnnotatorNotes T53	C3274653; Core Specimen; Body Substance
T54	Route 79 90	intravenosa
#42	AnnotatorNotes T54	C1522726; Intravenous Route of Drug Administration; Functional Concept
T55	Route 116 130	periprostática
#43	AnnotatorNotes T55	C1519008; Periprostatic; Spatial Concept
T56	Route 230 241	intravenosa
#44	AnnotatorNotes T56	C1522726; Intravenous Route of Drug Administration; Functional Concept
T57	Route 292 306	periprostático
#45	AnnotatorNotes T57	C1519008; Periprostatic; Spatial Concept
T58	Route 355 369	periprostática
#46	AnnotatorNotes T58	C1519008; Periprostatic; Spatial Concept
T59	LIVB 433 442	pacientes
#47	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 513 522	pacientes
#48	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	LIVB 550 559	pacientes
#49	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Dose 585 590	50 mg
T63	Route 605 616	intravenosa
#50	AnnotatorNotes T63	C1522726; Intravenous Route of Drug Administration; Functional Concept
T64	LIVB 631 640	pacientes
#51	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	Dose 654 658	5 mL
T66	Dose 672 677	al 2%
T70	Age 1115 1122	66 años
T72	LIVB 1310 1319	pacientes
#52	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T75	DEVI 1567 1578	transductor
#53	AnnotatorNotes T75	C0040661; Transducers; Medical Device
T79	LIVB 2000 2009	pacientes
#54	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T81	Route 2147 2161	periprostático
#55	AnnotatorNotes T81	C1519008; Periprostatic; Spatial Concept
T84	DEVI 2333 2344	transductor
#56	AnnotatorNotes T84	C0040661; Transducers; Medical Device
T67	Age 1124 1129	47-80
T68	Neg_cue 1240 1243	sin
T69	CONC 1244 1255	diferencias
A1	Assertion T69 Negated
#57	AnnotatorNotes T69	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T68 Arg2:T69	
T71	Neg_cue 1480 1483	sin
T73	CONC 1484 1495	diferencias
A2	Assertion T73 Negated
#58	AnnotatorNotes T73	C1705241; Delta (difference); Quantitative Concept
R2	Negation Arg1:T71 Arg2:T73	
T74	Neg_cue 2075 2078	sin
T76	CONC 2088 2099	diferencias
A3	Assertion T76 Negated
#59	AnnotatorNotes T76	C1705241; Delta (difference); Quantitative Concept
R3	Negation Arg1:T74 Arg2:T76	
T77	CONC 1040 1059	test no paramétrico
#60	AnnotatorNotes T77	C1709255; Non-Parametric Test; Intellectual Product
T78	Neg_cue 2176 2178	no
T80	CONC 2186 2206	ventajas analgésicas
A4	Assertion T80 Negated
R4	Negation Arg1:T78 Arg2:T80	
T82	Neg_cue 2281 2283	no
T83	CONC 2284 2291	aumenta
A5	Assertion T83 Negated
#61	AnnotatorNotes T83	C0442805; Increase; Functional Concept
R5	Negation Arg1:T82 Arg2:T83	
T85	CONC 1744 1755	diferencias
A6	Assertion T85 Negated
T86	Neg_cue 1729 1731	No
R6	Negation Arg1:T86 Arg2:T85	
T87	Neg_cue 1929 1936	tampoco
T88	CONC 1945 1956	diferencias
A7	Assertion T88 Negated
#62	AnnotatorNotes T88	C1705241; Delta (difference); Quantitative Concept
R7	Negation Arg1:T87 Arg2:T88	
#63	AnnotatorNotes T85	C1705241; Delta (difference); Quantitative Concept
R8	Has_Route_or_Mode Arg1:T2 Arg2:T54	
R9	Used_for Arg1:T4 Arg2:T3	
R10	Has_Route_or_Mode Arg1:T4 Arg2:T55	
R11	Before Arg1:T2 Arg2:T5	
R12	Before Arg1:T3 Arg2:T5	
R13	Location_of Arg1:T6 Arg2:T5	
R14	Has_Route_or_Mode Arg1:T9 Arg2:T56	
R15	Used_for Arg1:T9 Arg2:T8	
R16	Has_Route_or_Mode Arg1:T12 Arg2:T57	
R17	Location_of Arg1:T11 Arg2:T35	
R18	Used_for Arg1:T12 Arg2:T35	
T89	Quantifier_or_Qualifier 455 462	primera
#64	AnnotatorNotes T89	C0205435; First (number); Quantitative Concept 
R19	Location_of Arg1:T36 Arg2:T15	
R20	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T89	
T90	Quantifier_or_Qualifier 465 472	segunda
#65	AnnotatorNotes T90	C0205436; second (number); Quantitative Concept
R21	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T90	
R22	Experiences Arg1:T59 Arg2:T15	
R23	Experiences Arg1:T61 Arg2:T37	
R24	Has_Route_or_Mode Arg1:T37 Arg2:T63	
R25	Has_Dose_or_Strength Arg1:T37 Arg2:T62	
R26	Experiences Arg1:T60 Arg2:T37	
R27	Experiences Arg1:T60 Arg2:T17	
R28	Location_of Arg1:T16 Arg2:T17	
R29	Has_Dose_or_Strength Arg1:T17 Arg2:T66	
R30	Has_Dose_or_Strength Arg1:T17 Arg2:T65	
R31	Experiences Arg1:T64 Arg2:T17	
R36	Causes Arg1:T40 Arg2:T38	
R38	Before Arg1:T20 Arg2:T41	
R39	After Arg1:T18 Arg2:T19	
R40	Before Arg1:T19 Arg2:T41	
T91	CONC 1000 1020	test de chi cuadrado
#66	AnnotatorNotes T91	C0008041; Chi-Square Test; Intellectual Product
T92	CONC 1025 1037	t de Student
#67	AnnotatorNotes T92	C0871453; Students T Test; Intellectual Product
T93	CONC 1063 1077	Kruskal-Wallis
#68	AnnotatorNotes T93	C1708614; Kruskal-Wallis Test; Intellectual Product
R41	Location_of Arg1:T22 Arg2:T21	
T94	CONC 1199 1218	número de cilindros
T95	Observation 1221 1238	nivel de estudios
#69	AnnotatorNotes T95	C0013658; Educational Status; Finding
T96	Quantifier_or_Qualifier 1256 1270	significativas
A8	Assertion T96 Negated
#70	AnnotatorNotes T96	C0237881; Statistical Significance; Quantitative Concept
R42	Has_Quantifier_or_Qualifier Arg1:T69 Arg2:T96	
R43	Negation Arg1:T68 Arg2:T96	
T97	Quantifier_or_Qualifier 1288 1295	primera
R44	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T97	
#71	AnnotatorNotes T97	C0205435; First (number); Quantitative Concept
R45	Experiences Arg1:T72 Arg2:T23	
T98	Quantifier_or_Qualifier 1344 1351	segunda
R46	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T98	
#72	AnnotatorNotes T98	C0205436; second (number); Quantitative Concept
T99	Quantifier_or_Qualifier 1496 1510	significativas
A9	Assertion T99 Negated
#73	AnnotatorNotes T99	C0237881; Statistical Significance; Quantitative Concept
R47	Has_Quantifier_or_Qualifier Arg1:T73 Arg2:T99	
R48	Negation Arg1:T71 Arg2:T99	
R49	Causes Arg1:T75 Arg2:T46	
R50	Causes Arg1:T24 Arg2:T46	
T100	Observation 1828 1845	nivel de estudios
#74	AnnotatorNotes T100	C0013658; Educational Status; Finding
R51	Causes Arg1:T49 Arg2:T48	
R52	Before Arg1:T49 Arg2:T25	
T101	CONC 1899 1918	número de cilindros
R53	Experiences Arg1:T79 Arg2:T26	
R54	Experiences Arg1:T79 Arg2:T27	
R55	Experiences Arg1:T79 Arg2:T28	
R56	Before Arg1:T27 Arg2:T26	
R57	Before Arg1:T28 Arg2:T26	
R58	Has_Route_or_Mode Arg1:T31 Arg2:T81	
R59	Location_of Arg1:T30 Arg2:T29	
R60	Used_for Arg1:T31 Arg2:T29	
R61	Has_Route_or_Mode Arg1:T12 Arg2:T58	
R62	Used_for Arg1:T12 Arg2:T13	
R63	Before Arg1:T35 Arg2:T13	
R64	Before Arg1:T29 Arg2:T33	
R65	Before Arg1:T32 Arg2:T33	
T102	Quantifier_or_Qualifier 2345 2357	transrrectal
#75	AnnotatorNotes T102	C0205518; Transrectal approach; Functional Concept
R66	Has_Quantifier_or_Qualifier Arg1:T84 Arg2:T102	
R67	Causes Arg1:T84 Arg2:T52	
R68	Causes Arg1:T51 Arg2:T52	
T103	CONC 1356 1362;1369 1381	número de cilindros
#76	AnnotatorNotes T94	C1718405; Total number of cores; Quantitative Concept
#77	AnnotatorNotes T103	C1718405; Total number of cores; Quantitative Concept
#78	AnnotatorNotes T101	C1718405; Total number of cores; Quantitative Concept
#79	AnnotatorNotes T51	C3846093; Core biopsy (histology); Diagnostic Procedure
#80	AnnotatorNotes T24	C3846093; Core biopsy (histology); Diagnostic Procedure
A10	Experiencer T59 Patient
A11	Experiencer T60 Patient
A12	Experiencer T61 Patient
A13	Experiencer T64 Patient
A14	Experiencer T72 Patient
A15	Experiencer T79 Patient
